Market Tracker

11/27 9:02am ET

Dynavax Technologies Corp (NASDAQ:DVAX)

15.10
Data as of Nov 26
 +0.72 / +5.01%
Today’s Change
12.50
Today|||52-Week Range
21.40
-22.96%
Year-to-Date
Frontrunning: November 5
Nov 23 / Investing Channel
 

Today’s Trading

Previous close14.38
Today’s open14.43
Day’s range14.24 - 15.27
Volume319,975
Average volume (3 months)248,758
Market cap$397.0M
Dividend yield--
Data as of 4:00pm ET, 11/26/2014

Growth & Valuation

Earnings growth (last year)+7.32%
Earnings growth (this year)-940.79%
Earnings growth (next 5 years)--
Revenue growth (last year)+15.82%
P/E ratioNM
Price/Sales34.19
Price/Book2.13

Competitors

 Today’s
change
Today’s
% change
SUPNSupernus Pharmaceuti...+0.04+0.45%
TKMRTekmira Pharmaceutic...-0.18-1.10%
RVNCRevance Therapeutics...+0.05+0.30%
PRQRProQR Therapeutics N...+0.13+0.86%
Data as of 4:00pm ET, 11/26/2014

Financials

Next reporting dateMarch 3, 2015
EPS forecast (this quarter)-$1.07
Annual revenue (last year)$11.3M
Annual profit (last year)-$66.7M
Net profit margin-593.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts